Luminex Corporation (LMNX): Price and Financial Metrics

Luminex Corporation (LMNX): $36.99

0.01 (+0.03%)

POWR Rating

Component Grades














  • Value is the dimension where LMNX ranks best; there it ranks ahead of 84.27% of US stocks.
  • The strongest trend for LMNX is in Momentum, which has been heading down over the past 31 weeks.
  • LMNX ranks lowest in Sentiment; there it ranks in the 6th percentile.

LMNX Stock Summary

  • Price to trailing twelve month operating cash flow for LMNX is currently 49.18, higher than 90.75% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 1,509.55%, Luminex Corp's debt growth rate surpasses 98.73% of about US stocks.
  • Over the past twelve months, LMNX has reported earnings growth of -1,177.24%, putting it ahead of only 1.53% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Luminex Corp are ONTO, INTT, SWBI, SIGA, and EGY.
  • LMNX's SEC filings can be seen here. And to visit Luminex Corp's official web site, go to

LMNX Valuation Summary

  • In comparison to the median Healthcare stock, LMNX's EV/EBIT ratio is 15.94% higher, now standing at 33.1.
  • LMNX's price/sales ratio has moved down 44.8 over the prior 243 months.
  • LMNX's price/sales ratio has moved down 44.8 over the prior 243 months.

Below are key valuation metrics over time for LMNX.

Stock Date P/S P/B P/E EV/EBIT
LMNX 2017-10-20 3.0 2.2 64.9 34.8
LMNX 2016-10-11 4.0 2.5 24.2 24.3
LMNX 2014-12-26 3.6 2.8 38.1 31.0
LMNX 2009-08-07 5.9 3.3 185.5 121.1
LMNX 2009-05-14 6.1 3.4 456.0 198.8
LMNX 2004-03-31 10.5 6.2 -65.7 -56.3

LMNX Price Target

For more insight on analysts targets of LMNX, see our LMNX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $37.00 Average Broker Recommendation 2 (Hold)

LMNX Stock Price Chart Interactive Chart >

Price chart for LMNX

LMNX Price/Volume Stats

Current price $36.99 52-week high $41.69
Prev. close $36.98 52-week low $20.61
Day low $36.98 Volume 1,019,200
Day high $37.00 Avg. volume 873,093
50-day MA $36.79 Dividend yield 1.08%
200-day MA $29.93 Market Cap 1.75B

Luminex Corporation (LMNX) Company Bio

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics and life sciences industries worldwide. The company was founded in 1995 and is based in Austin, Texas.

LMNX Latest News Stream

Event/Time News Detail
Loading, please wait...

LMNX Latest Social Stream

Loading social stream, please wait...

View Full LMNX Social Stream

Latest LMNX News From Around the Web

Below are the latest news stories about Luminex Corp that investors may wish to consider to help them evaluate LMNX as an investment opportunity.

Hot Stocks: Earnings drive moves in PEP, NOK, SLP; PLXP gets Walmart boost; MSEX added to SmallCap 600

primeimages/E+ via Getty Images Earnings season is here. Several big-name stocks got a boost in Tuesday's pre-market action thanks to strong financial figures. PepsiCo (PEP) posted gains following its earnings report, while Nokia (NOK) jumped on strong guidance. Simulations Plus (SLP) moved the other direction on earnings news. Shares posted...

Seeking Alpha | July 13, 2021

Here is What Hedge Funds Think About Luminex Corporation (LMNX)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 866 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

Yahoo | July 13, 2021

Middlesex Water Set to Join S&P SmallCap 600

Middlesex Water Co. (NASD: MSEX) will replace Luminex Corp. (NASD: LMNX) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, July 15. DiaSorin S.p.A. is acquiring Luminex in a deal expected to be completed soon pending final closing conditions.

Yahoo | July 12, 2021

STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / June 11, 2021 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating: * Domtar Corp. (NYSE:UFS) relating to its proposed acquisition by Paper Excellence.

Yahoo | June 12, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNBKA, WRI, FI, SNX, ORBC, LMNX; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | June 8, 2021

Read More 'LMNX' Stories Here

LMNX Price Returns

1-mo N/A
3-mo 0.71%
6-mo 18.88%
1-year 48.30%
3-year 30.59%
5-year 74.61%
YTD 60.92%
2020 1.20%
2019 1.58%
2018 18.40%
2017 -1.42%
2016 -5.42%

LMNX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LMNX Dividend History

Continue Researching LMNX

Want to see what other sources are saying about Luminex Corp's financials and stock price? Try the links below:

Luminex Corp (LMNX) Stock Price | Nasdaq
Luminex Corp (LMNX) Stock Quote, History and News - Yahoo Finance
Luminex Corp (LMNX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0053 seconds.